MGH-CP1

N/A

Report date: 2022/11/15 15:00:34
NME

Base Information

Drug NameMGH-CP1
Drug Alias NameMGH-CP-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHarvard Medical SchoolXuzhou Medical University (Xzmu)
China Registration ClassN/A

Develop Information

Active CompaniesHarvard Medical SchoolXuzhou Medical University (Xzmu)
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A